CLINICAL_TRIALS
trial_result
· 2020-08-18
Clinical Trial Update: Long Term Safety Study of Plecanatide [Phase 3]
Summary
Phase 3 long-term safety study of plecanatide in irritable bowel syndrome completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-08-18